BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 23530123)

  • 1. Specific Notch receptor-ligand interactions control human TCR-αβ/γδ development by inducing differential Notch signal strength.
    Van de Walle I; Waegemans E; De Medts J; De Smet G; De Smedt M; Snauwaert S; Vandekerckhove B; Kerre T; Leclercq G; Plum J; Gridley T; Wang T; Koch U; Radtke F; Taghon T
    J Exp Med; 2013 Apr; 210(4):683-97. PubMed ID: 23530123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-like 4-mediated Notch signaling is required for early T-cell development in a three-dimensional thymic structure.
    Hirano K; Negishi N; Yazawa M; Yagita H; Habu S; Hozumi K
    Eur J Immunol; 2015 Aug; 45(8):2252-62. PubMed ID: 25976373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An early decrease in Notch activation is required for human TCR-alphabeta lineage differentiation at the expense of TCR-gammadelta T cells.
    Van de Walle I; De Smet G; De Smedt M; Vandekerckhove B; Leclercq G; Plum J; Taghon T
    Blood; 2009 Mar; 113(13):2988-98. PubMed ID: 19056690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression pattern of notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development.
    Felli MP; Maroder M; Mitsiadis TA; Campese AF; Bellavia D; Vacca A; Mann RS; Frati L; Lendahl U; Gulino A; Screpanti I
    Int Immunol; 1999 Jul; 11(7):1017-25. PubMed ID: 10383933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. αβ versus γδ fate choice: counting the T-cell lineages at the branch point.
    Kreslavsky T; Gleimer M; Garbe AI; von Boehmer H
    Immunol Rev; 2010 Nov; 238(1):169-81. PubMed ID: 20969592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential synergy of Notch and T cell receptor signaling determines alphabeta versus gammadelta lineage fate.
    Garbe AI; Krueger A; Gounari F; Zúñiga-Pflücker JC; von Boehmer H
    J Exp Med; 2006 Jun; 203(6):1579-90. PubMed ID: 16754723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. αβ and γδ T cell receptors: Similar but different.
    Morath A; Schamel WW
    J Leukoc Biol; 2020 Jun; 107(6):1045-1055. PubMed ID: 31994778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Notch activity influences the alphabeta versus gammadelta T cell lineage decision.
    Washburn T; Schweighoffer E; Gridley T; Chang D; Fowlkes BJ; Cado D; Robey E
    Cell; 1997 Mar; 88(6):833-43. PubMed ID: 9118226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human alpha beta and gamma delta thymocyte development: TCR gene rearrangements, intracellular TCR beta expression, and gamma delta developmental potential--differences between men and mice.
    Joachims ML; Chain JL; Hooker SW; Knott-Craig CJ; Thompson LF
    J Immunol; 2006 Feb; 176(3):1543-52. PubMed ID: 16424183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jagged2 acts as a Delta-like Notch ligand during early hematopoietic cell fate decisions.
    Van de Walle I; De Smet G; Gärtner M; De Smedt M; Waegemans E; Vandekerckhove B; Leclercq G; Plum J; Aster JC; Bernstein ID; Guidos CJ; Kyewski B; Taghon T
    Blood; 2011 Apr; 117(17):4449-59. PubMed ID: 21372153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alphabeta versus gammadelta lineage choice at the first TCR-controlled checkpoint.
    Kreslavsky T; Gleimer M; von Boehmer H
    Curr Opin Immunol; 2010 Apr; 22(2):185-92. PubMed ID: 20074925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage divergence at the first TCR-dependent checkpoint: preferential γδ and impaired αβ T cell development in nonobese diabetic mice.
    Feng N; Vegh P; Rothenberg EV; Yui MA
    J Immunol; 2011 Jan; 186(2):826-37. PubMed ID: 21148803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of Notch signaling in human tongue carcinoma.
    Zhang TH; Liu HC; Zhu LJ; Chu M; Liang YJ; Liang LZ; Liao GQ
    J Oral Pathol Med; 2011 Jan; 40(1):37-45. PubMed ID: 20819128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TCR-beta chains derived from peripheral gammadelta T cells can take part in alphabeta T-cell development.
    Bosco N; Engdahl C; Bénard A; Rolink J; Ceredig R; Rolink AG
    Eur J Immunol; 2008 Dec; 38(12):3520-9. PubMed ID: 18991270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of Notch in activation and effector functions of γδ T cells.
    Gogoi D; Dar AA; Chiplunkar SV
    J Immunol; 2014 Mar; 192(5):2054-62. PubMed ID: 24489102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.
    Dolens AC; Durinck K; Lavaert M; Van der Meulen J; Velghe I; De Medts J; Weening K; Roels J; De Mulder K; Volders PJ; De Preter K; Kerre T; Vandekerckhove B; Leclercq G; Vandesompele J; Mestdagh P; Van Vlierberghe P; Speleman F; Taghon T
    EMBO Rep; 2020 May; 21(5):e49006. PubMed ID: 32255245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL4-mediated Notch signaling is required for the development of fetal αβ and γδ T cells.
    Ferrero I; Koch U; Claudinot S; Favre S; Radtke F; Luther SA; MacDonald HR
    Eur J Immunol; 2013 Nov; 43(11):2845-53. PubMed ID: 23881845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision checkpoints in the thymus.
    Carpenter AC; Bosselut R
    Nat Immunol; 2010 Aug; 11(8):666-73. PubMed ID: 20644572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained Notch1 signaling instructs the earliest human intrathymic precursors to adopt a gammadelta T-cell fate in fetal thymus organ culture.
    García-Peydró M; de Yébenes VG; Toribio ML
    Blood; 2003 Oct; 102(7):2444-51. PubMed ID: 12829602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage-specific and differential notch dependency at the alphabeta and gammadelta T lineage bifurcation.
    Ciofani M; Knowles GC; Wiest DL; von Boehmer H; Zúñiga-Pflücker JC
    Immunity; 2006 Jul; 25(1):105-16. PubMed ID: 16814577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.